Smith & Nephew (SNNUF) Net Income towards Common Stockholders (2009 - 2024)

Smith & Nephew (SNNUF) reported Net Income towards Common Stockholders of $253.0 million for Q4 2024, up 19.91% on a YoY basis from $211.0 million in Q1 2024, and up 19.91% quarter-over-quarter from $211.0 million in Q4 2023.

Smith & Nephew (SNNUF) Net Income towards Common Stockholders (2009 - 2024) Analysis & Trends

Smith & Nephew has reported Net Income towards Common Stockholders for 16 years, with the latest figure at $253.0 million in Q4 2024.

  • For the quarter ending Q4 2024, Net Income towards Common Stockholders rose 19.91% year-over-year to $253.0 million; the trailing twelve-month figure through Dec 2025 stood at $253.0 million (down 62.13% YoY), and the FY2025 full-year result was $625.0 million, up 51.7% from the prior year.
  • Net Income towards Common Stockholders for Q4 2024 stood at $253.0 million, up from $211.0 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $253.0 million in Q4 2024, with the low at -$34.0 million in Q4 2020.
  • Historically, Net Income towards Common Stockholders has averaged $171.4 million across 5 years, with a median of $211.0 million in 2023.
  • Annual changes were most pronounced in 2020 — Net Income towards Common Stockholders tumbled 108.88% — and 2021, when it jumped 755.88%.
  • Smith & Nephew's Net Income towards Common Stockholders stood at -$34.0 million in 2020, then jumped by 755.88% to $223.0 million in 2021, then dropped by 8.52% to $204.0 million in 2022, then climbed by 3.43% to $211.0 million in 2023, then advanced by 19.91% to $253.0 million in 2024.
  • The last three Net Income towards Common Stockholders figures came in at $253.0 million (Q4 2024), $211.0 million (Q4 2023), and $204.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Smith & Nephew - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 253.00 Mn
Dec 31, 2023 211.00 Mn
Dec 31, 2022 204.00 Mn
Dec 31, 2021 223.00 Mn
Dec 31, 2020 -34.00 Mn
Dec 31, 2019 383.00 Mn
Dec 31, 2018 341.00 Mn
Dec 31, 2017 383.00 Mn
Dec 31, 2016 327.00 Mn
Dec 31, 2015 411.00 Mn
Dec 31, 2014 1.03 Bn
Sep 30, 2014 153.00 Mn
Mar 31, 2014 212.00 Mn
Dec 31, 2013 204.00 Mn
Sep 28, 2013 180.00 Mn
Jun 29, 2013 188.00 Mn
Mar 31, 2013 232.00 Mn
Dec 31, 2012 231.00 Mn
Sep 29, 2012 187.00 Mn
Jun 30, 2012 475.00 Mn